Richard A Brook

Summary

Publications

  1. ncbi request reprint Absenteeism and productivity among employees being treated for hepatitis C
    Richard A Brook
    Retrospective Analysis, The JeSTARx Group, Newfoundland, NJ 07435 1710, USA
    Am J Manag Care 17:657-64. 2011
  2. doi request reprint Absenteeism and health-benefit costs among employees with MS
    Richard A Brook
    Retrospective Research, The JeSTARx Group, Newfoundland, NJ 07435 1710, USA
    Curr Med Res Opin 25:1469-76. 2009
  3. doi request reprint Functional dyspepsia impacts absenteeism and direct and indirect costs
    Richard A Brook
    Retrospective Analysis, The JeSTARx Group, Newfoundland, New Jersey 07435 1710, USA
    Clin Gastroenterol Hepatol 8:498-503. 2010
  4. ncbi request reprint Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States
    R A Brook
    The JeSTARx Group, Newfoundland, NJ 07435 1710, USA
    Aliment Pharmacol Ther 26:889-98. 2007
  5. doi request reprint Chronic gout: epidemiology, disease progression, treatment and disease burden
    Richard A Brook
    The JeSTARx Group, Newfoundland, NJ, USA
    Curr Med Res Opin 26:2813-21. 2010
  6. ncbi request reprint Employee costs before and after treatment initiation for bipolar disorder
    Richard A Brook
    Retrospective Analysis, The JeSTARx Group, Newfoundland, NJ 07435 1710, USA
    Am J Manag Care 13:179-86. 2007
  7. doi request reprint Excess comorbidity prevalence and cost associated with functional dyspepsia in an employed population
    Richard A Brook
    The JeSTARx Group, 18 Hirth Drive, Newfoundland, NJ 07435 1710, USA
    Dig Dis Sci 57:109-18. 2012
  8. ncbi request reprint Absenteeism and productivity among employees being treated for hepatitis c
    Richard A Brook
    Retrospective Analysis, The JeSTARx Group, 18 Hirth Dr, Newfoundland, NJ 07435 1710 E mail
    Am J Manag Care 17:657-64. 2011
  9. ncbi request reprint The economic burden of gout on an employed population
    Richard A Brook
    The JeSTARx Group, Newfoundland, NJ 07435 1710, USA
    Curr Med Res Opin 22:1381-9. 2006
  10. doi request reprint Annual incremental health benefit costs and absenteeism among employees with and without rheumatoid arthritis
    Nathan L Kleinman
    Data Analytics, HCMS Group, Cheyenne, WY, USA
    J Occup Environ Med 55:240-4. 2013

Collaborators

Detail Information

Publications17

  1. ncbi request reprint Absenteeism and productivity among employees being treated for hepatitis C
    Richard A Brook
    Retrospective Analysis, The JeSTARx Group, Newfoundland, NJ 07435 1710, USA
    Am J Manag Care 17:657-64. 2011
    ..To compare productivity, absence days, and absence costs for treated (HCV-Tx) and untreated (HCV-NoTx) US employees with hepatitis C virus (HCV) infection...
  2. doi request reprint Absenteeism and health-benefit costs among employees with MS
    Richard A Brook
    Retrospective Research, The JeSTARx Group, Newfoundland, NJ 07435 1710, USA
    Curr Med Res Opin 25:1469-76. 2009
    ..The purpose of this analysis was to assess the differences in lost time and health-benefit costs (HBCs) among employees treated with disease modifying treatments (DMTs) for multiple sclerosis (MS)...
  3. doi request reprint Functional dyspepsia impacts absenteeism and direct and indirect costs
    Richard A Brook
    Retrospective Analysis, The JeSTARx Group, Newfoundland, New Jersey 07435 1710, USA
    Clin Gastroenterol Hepatol 8:498-503. 2010
    ..Few data on absenteeism and no objective information are available. This study aimed to assess the impact of FD on costs and effects on absenteeism and work output (productivity)...
  4. ncbi request reprint Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States
    R A Brook
    The JeSTARx Group, Newfoundland, NJ 07435 1710, USA
    Aliment Pharmacol Ther 26:889-98. 2007
    ..Employers pay more than just salary for their employees. Previous studies have largely focused on direct medical and prescription drug costs of gastro-oesophageal reflux disease (GERD), and few have reported on total absenteeism costs...
  5. doi request reprint Chronic gout: epidemiology, disease progression, treatment and disease burden
    Richard A Brook
    The JeSTARx Group, Newfoundland, NJ, USA
    Curr Med Res Opin 26:2813-21. 2010
    ..Diagnosed gout cases have been estimated at 2.13% of the 2009 US population. The highest incidence occurs in the 65+ year age group, with males more than twice as likely to be afflicted as females...
  6. ncbi request reprint Employee costs before and after treatment initiation for bipolar disorder
    Richard A Brook
    Retrospective Analysis, The JeSTARx Group, Newfoundland, NJ 07435 1710, USA
    Am J Manag Care 13:179-86. 2007
    ..To examine pretreatment and posttreatment total medical costs and overall mental healthcare costs for patients with bipolar disorder (BPD) treated with different medication regimens (alone and in combination) vs an untreated (UnTx) cohort...
  7. doi request reprint Excess comorbidity prevalence and cost associated with functional dyspepsia in an employed population
    Richard A Brook
    The JeSTARx Group, 18 Hirth Drive, Newfoundland, NJ 07435 1710, USA
    Dig Dis Sci 57:109-18. 2012
    ..Limited published data exist on the associated comorbid conditions with functional dyspepsia (FD)...
  8. ncbi request reprint Absenteeism and productivity among employees being treated for hepatitis c
    Richard A Brook
    Retrospective Analysis, The JeSTARx Group, 18 Hirth Dr, Newfoundland, NJ 07435 1710 E mail
    Am J Manag Care 17:657-64. 2011
    ..New treatments are needed with improved adverse effect profiles that result in reduced absence from work and improved productivity among HCV-infected persons...
  9. ncbi request reprint The economic burden of gout on an employed population
    Richard A Brook
    The JeSTARx Group, Newfoundland, NJ 07435 1710, USA
    Curr Med Res Opin 22:1381-9. 2006
    ....
  10. doi request reprint Annual incremental health benefit costs and absenteeism among employees with and without rheumatoid arthritis
    Nathan L Kleinman
    Data Analytics, HCMS Group, Cheyenne, WY, USA
    J Occup Environ Med 55:240-4. 2013
    ..To assess the impact of rheumatoid arthritis (RA) on absence time, absence payments, and other health benefit costs from the perspective of US employers...
  11. ncbi request reprint Lost time, absence costs, and reduced productivity output for employees with bipolar disorder
    Nathan L Kleinman
    HCMS Group, Cheyenne, Wyoming 82001, USA
    J Occup Environ Med 47:1117-24. 2005
    ..We sought to evaluate the incremental health-related lost work time and at-work productivity loss for employees with bipolar disorder (BPD)...
  12. ncbi request reprint The economic impact of bipolar disorder in an employed population from an employer perspective
    Harold H Gardner
    Human Capital Management Services, Cheyenne, WY 82001, USA
    J Clin Psychiatry 67:1209-18. 2006
    ..To determine the economic impact of bipolar disorder on health benefit costs and health-related work absences from an employer perspective...
  13. ncbi request reprint Costs of physical and mental comorbidities among employees: a comparison of those with and without bipolar disorder
    Krithika Rajagopalan
    Health Economics Outcomes Research, AstraZeneca Pharmaceuticals, Wilmington, DE 19850 5437, USA
    Curr Med Res Opin 22:443-52. 2006
    ..To compare the cost and utilization of health care services for various comorbid conditions among employees with bipolar disorder (BPD) and two other population cohorts: employees without BPD and employees with other mental disorders (OMD)...
  14. doi request reprint Objective measurement of work absence and on-the-job productivity: a case-control study of US employees with and without gastroesophageal reflux disease
    Peter Wahlqvist
    AstraZeneca R and D Molndal, Molndal, Sweden
    J Occup Environ Med 50:25-31. 2008
    ..To establish an association between gastroesophageal reflux disease (GERD) and increased work absence, as well as reduced productivity while at work, by using objective productivity measurements...
  15. ncbi request reprint The impact of gout on work absence and productivity
    Nathan L Kleinman
    HCMS Group, Cheyenne, WY 82001, USA
    Value Health 10:231-7. 2007
    ..The goal of this analysis was to evaluate the impact of gout, a painful inflammatory arthritis condition, on an employed population's health-related work absence and objectively measured productivity output...
  16. ncbi request reprint Metabolic syndrome-related conditions among people with and without gout: prevalence and resource use
    Suzanne Novak
    Pharmacy Practice, University of Texas at Austin, Austin, TX, USA
    Curr Med Res Opin 23:623-30. 2007
    ....
  17. ncbi request reprint Exploratory economic evaluation of patients with COPD on a combination product versus individual components (ipratropium bromide and albuterol)
    John M York
    Akita Biomedical Consulting, San Clemente, California 92672, USA
    Adv Ther 24:757-71. 2007
    ..Future analyses should include clinical data to better elucidate the full impact of DN on healthcare resources and compliance in the COPD population...